Adaptive Biotechnologies (ADPT) Misses Q4 EPS by 18c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $25.49 +3.79%
Financial Fact:
Total operating expenses: 36.9M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Total operating expenses: 36.9M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.48), $0.18 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $45.78 million versus the consensus estimate of $48.45 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Lowe's slashes full-year sales outlook amid DIY spending pressure
- Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
